Michael Phillip Weiner

Title: Michael Phillip Weiner: Innovator in Protein-Protein Interaction Assays

Introduction

Michael Phillip Weiner is a notable inventor based in Cary, NC (US). He has made significant contributions to the field of biotechnology, particularly in the development of methods for studying protein interactions. With a total of 2 patents, Weiner's work has implications for various applications in medical and biological research.

Latest Patents

Weiner's latest patents include innovative technologies that enhance the understanding of protein interactions. One of his patents focuses on assay methods, specifically an automated format for the yeast two-hybrid assay for protein-protein interactions. This invention streamlines the process of studying how proteins interact, which is crucial for understanding cellular functions and disease mechanisms. Another significant patent is for a system for generating recombinant viruses. This invention provides a simplified approach to creating recombinant animal viruses, utilizing a virus homing vector and a transfer vector. This system reduces the number of cloning steps required and facilitates the preparation of various recombinant viruses.

Career Highlights

Michael Phillip Weiner is associated with Glaxo Wellcome Inc., a prominent company in the pharmaceutical industry. His work at Glaxo Wellcome has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Weiner has worked alongside notable colleagues, including Cynthia A. Richards and Richard Gordon Buckholz. Their combined expertise has fostered an environment of innovation and discovery.

Conclusion

Michael Phillip Weiner's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact research in protein interactions and recombinant virus generation.